BURNABY, Canada, December 7, 2015 /PRNewswire/ --
Growing prevalence of autoimmune disorders and various ongoing technological advancements to drive the United States autoimmune disorders diagnostics market
According to recently published Pharmaion report, "United States Autoimmune Disorders Diagnostics Market Opportunities, 2020", the autoimmune disorders diagnostics market in the United States is anticipated to cross $6 billion sales by 2020. Some of the major autoimmune diseases include Rheumatoid Arthritis, Type 1 Diabetes, Multiple Sclerosis, Systemic Lupus Erythematosus (SLE), Inflammatory Bowel Disease (IBD), Psoriasis and Autoimmune Thyroiditis, etc. According to American Autoimmune Related Diseases Association (AARDA), 50 million Americans are suffering from more than 100 types of autoimmune disorders, and 75-85% of the total autoimmune disorders patients in the country are women.
Growth in the market is anticipated on account of growing disease burden of various autoimmune disorders, increasing healthcare expenditure and various ongoing technological advancements. Moreover, increasing automation in laboratories leading to precise and faster diagnosis is forecast to further upsurge the market of autoimmune disorders diagnostics in the US during 2015 - 2020. On the basis of target disease, the market is broadly segmented into two categories, namely, systemic autoimmune disorders diagnostics and localized autoimmune disorders diagnostics. Among these two categories, systemic autoimmune disorders diagnostics segment dominated the autoimmune disorders diagnostics market in 2014, and the segment is anticipated to continue its dominance through 2020 on account of increasing ongoing research activities that are focused on developing tests and technologies that would precisely detect the abnormalities in organ functioning and deliver faster diagnosis.
"With growing adoption of biomarkers, Lab-on-Chip devices and portable diagnostic equipment, the market for autoimmune disorders diagnostics in the US is anticipated to grow over the next five years. Moreover, National Institute of Allergy and Infectious Diseases (NIAID) is organizing a clinical research program - Autoimmunity Centre of Excellence (ACEs) for effective diagnosis and treatment of autoimmune diseases by expanding collaborative research across medical specialties, scientific disciplines, and basic & clinical scientists.", said Mr. Brijesh Khurana, Consultant at Pharmaion, a research based global pharmaceutical and healthcare consulting firm.
"United States Autoimmune Disorders Diagnostics Market Opportunities, 2020" has evaluated the future growth potential of the US autoimmune disorders diagnostics market and provides statistics and information on market structure, industry behavior and trends. The report is intended to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyzes emerging trends along with essential drivers, challenges and opportunities available in United States autoimmune disorders diagnostics market.
Pharmaion is a research based management consulting firm focused exclusively on Healthcare & Pharmaceutical industry. Led by a team of dynamic industry experts, Pharmaion provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share. As a result, Pharmaion's clients lead rather than follow market trends. Pharmaion has developed a proprietary database which focuses on identifying the unexplored opportunities in Healthcare and Pharmaceutical industry.
Contact Phone- +1 646 360 1656